GSK
Director, Oncology Translational Medicine, Clinical Biomarkers
$190K–$316K
USA - Pennsylvania - Upper Providence +3 · Hybrid (Remote & On-site) · Director · Full-time · Posted Oct 26, 2026
- Location
- USA - Pennsylvania - Upper Providence
GSK HQ
UK - Hertfordshire - Stevenage
Waltham - Experience
- 7+ years with a Ph.D. or equivalent, or 10+ years with an M.Sc., in pharmaceutical-industry drug development.
- Education
- Ph.D. or equivalent, or M.Sc.
About the job
Leads biomarker and translational medicine strategies for late-stage oncology clinical development, guiding patient selection, study design, and clinical decision-making.
What you'll do
- Develop and implement clinical biomarker strategies, including biomarker validation and plans for patient stratification, dose selection, and clinical go/no-go decisions.
- Lead biomarker strategy execution across oncology programs and clinical teams, coordinating internal and external stakeholders and integrating strategies into clinical studies.
- Oversee biomarker sample testing and data packages to inform clinical development, regulatory strategies, and asset decisions.
What they ask for
- Ph.D. or equivalent with 7+ years, or M.Sc. with 10+ years, of pharmaceutical-industry drug development experience.
- Strong background in oncology clinical biomarkers, late-phase oncology studies, and translational research within clinical development.
- Experience leading cross-functional teams and designing and executing strategic biomarker plans, including regulated biomarker assays.
- Hands-on experience with biomarker platforms including flow cytometry, NGS, FISH, PCR, IHC/IF, liquid biopsy/ctDNA, and multi-omic analyses.
Nice to have
- Experience with diagnostic development and regulatory interactions.
- Experience with digital pathology, AI/ML-enabled biomarker analyses, external scientific partnerships, and mentoring scientific colleagues.
Pay
$189,750 to $316,250 USD annual base salary
Tools
flow cytometry, NGS, FISH, PCR, IHC/IF, liquid biopsy / ctDNA, multi-omic biomarker analyses, AI/ML
AI focus
Preferred experience includes AI/ML-enabled biomarker analyses.
Model-written summary · the original posting is authoritative